Immunohistochemistry Can Act as a Surrogate to Aid Difficult Diagnoses of Soft Tissue Tumors
Immunohistochemistry (IHC) offers a reliable, cost-effective alternative to genetic testing for diagnosing soft tissue tumors.
Read MorePosted by Chris Wolski | Jun 26, 2025 | Histology |
Immunohistochemistry (IHC) offers a reliable, cost-effective alternative to genetic testing for diagnosing soft tissue tumors.
Read MorePosted by Chris Wolski | Jun 23, 2025 | Molecular Diagnostics |
Precision oncology is undergoing rapid transformation driven by NGS technology, but systemic barriers in testing access must be overcome.
Read MorePosted by Chris Wolski | Jun 20, 2025 | Infectious Diseases |
Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.
Read MorePosted by Chris Wolski | Jun 20, 2025 | Molecular Diagnostics |
Most Medicaid-enrolled children with autism or intellectual disability are not receiving recommended genetic testing.
Read MorePosted by Chris Wolski | Jun 18, 2025 | Cardiovascular |
Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.
Read More